1st Quarter - Report

DALRYMPLE & ASSOCIATES, LLC for SANOFI PASTEUR

Firm
Client
Income
$46,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Vaccine research and development legislation, funding, appropriations and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: Health Resources & Services Administration (HRSA); Defense Threat Reduction Agency (DTRA); Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); State, Dept of (DOS); Veterans Affairs, Dept of (VA); Army, Dept of (Other); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Defense, Dept of (DOD); White House Office

Health Issues HCR

Vaccine and immunization finance, reimbursement, acquisition, regulation, standards of quality and care, liability, public health and emergency preparedness funding, legislation, appropriations and oversight.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal

Contacted: State, Dept of (DOS); Natl Institutes of Health (NIH); U.S. Agency for International Development (USAID); SENATE; Defense Threat Reduction Agency (DTRA); White House Office; Army, Dept of (Other); Health Resources & Services Administration (HRSA); Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.